MRC Molecular Haematology Unit
We aim to understand how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders. Ultimately, our purpose is to improve the prognosis of patients with inherited and acquired blood diseases.
Unit Director
Sten Eirik W. Jacobsen new member of The Royal Swedish Academy of Sciences
Congratulations to Prof Jacobsen, who was elected member of the Academy's Class for Medical Sciences.
Read moreMRC WIMM appoints new Director
We are delighted to announce that Professor KJ Patel has been appointed as the new Director of the MRC Weatherall Institute of Molecular Medicine and the MRC Molecular Haematology Unit at the University of Oxford.
Read moreChildhood ALL: Same same but different!
For Childhood Cancer Awareness Month, Dr Andi Roy explains current challenges in the treatment of Acute Lymphoblastic Leukaemia and how research at the MRC WIMM is trying to tackle them.
Read moreDr Mira Kassouf recognised as one of the “50 Movers and Shakers in BioBusiness 2019”
Many congratulations to Dr Mira Kassouf, a researcher in the Higgs group, recognised for her efforts to break silos in life sciences with entrepreneurship.
Read moreLatest Publications
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs.
O'Byrne S. et al, (2019), Blood, 134, 1059 - 1071
A revised model for promoter competition based on multi-way chromatin interactions at the α-globin locus.
Oudelaar AM. et al, (2019), Nat Commun, 10
Single-cell analysis of bone marrow-derived CD34+ cells from children with sickle cell disease and thalassemia.
Hua P. et al, (2019), Blood, 134, 2111 - 2115
Stabilization of chromatin topology safeguards genome integrity
Ochs F. et al, (2019), Nature, 574, 571 - 574
Latest News
New Nature paper from incoming MRC WIMM Director
9 March 2020
MRC WIMM appoints new Director
4 March 2020